Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Advanced low-temperature selective hydrolysis method for cefuroxime acid production. High purity, reduced waste, and scalable manufacturing for global pharmaceutical supply chains.
Advanced synthesis of Remdesivir intermediates via optimized cyanation and ammonolysis. Reduces waste and improves scalability for pharmaceutical manufacturing.
Advanced enzymatic resolution synthesis for chiral antifungal intermediates. Cost-effective, scalable production of high-purity pharmaceutical ingredients with superior stereocontrol.
Novel route for Xofluza sulfur-heterocycle intermediate. Cost-effective, scalable, avoids cryogenic conditions. Ideal for API manufacturing.
Patent CN115850244B reveals a green cyanation route for Topiroxostat. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN115477627B reveals a novel copper-catalyzed route for 2-furanone compounds, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN1671686A reveals a stable route for thiophene intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN103360442B details a novel gold-catalyzed synthesis for protopanaxatriol ginsenosides. This report analyzes cost reduction in API manufacturing and supply chain reliability for high-purity ginsenosides.
Novel patent CN103965282A offers streamlined synthesis for Abiraterone Acetate ensuring high purity and scalable production for global supply chains.
Patent CN101798313B details a novel Cefdinir synthesis using stable AB-AE active ester, offering superior yield and storage stability for pharmaceutical manufacturing.
Novel Rh-free synthesis of Sitagliptin phosphate ensuring high purity and cost efficiency for pharmaceutical supply chains.
Patent CN112898368B reveals Pd-catalyzed route for obeticholic acid intermediate, offering mild conditions and supply chain stability for pharma manufacturing.
Patent CN103709179B details a high-purity Cefmetazole Sodium route using DCT. This report analyzes cost reduction and supply chain reliability for global buyers.
Patent CN113880901B reveals a metal-free asymmetric halocyclization route for high-purity nucleoside intermediates, offering significant cost reduction and supply chain reliability.
Advanced macroporous resin purification technology for Cefprozil ensures >99% purity. Discover cost-effective manufacturing solutions and scalable supply chain strategies.
Patent CN104557737A reveals high-yield Pd-catalyzed route. Enables cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN108147973B details a novel thiourea-catalyzed route for ECPPA, offering superior stereoselectivity and simplified processing for ACE inhibitor manufacturing.
Novel acidic resin catalysis for Trifluridine intermediate. Enhances purity above 98 percent, reduces emulsification, ensures scalable supply for pharmaceutical manufacturing.
Patent CN101270058B details a high-yield hydrogenation route for 3-(1-dimethylaminoethyl)phenol, offering superior purity and cost efficiency for Alzheimer's drug intermediates.
Patent CN110862421A reveals a safe 3-step synthesis avoiding hazardous reagents, ensuring high purity intermediates for reliable pharmaceutical intermediates supply chains.